The iconic media figure Oprah Winfrey announced this Friday her decision to leave her position on the board of directors of WeightWatchersmarking the end of an era for the weight loss and wellness company it has been closely associated with for years.
This news has surprised many, given the significant impact Winfrey has had on the company since her investment and her role as a brand ambassador. Her departure raises questions about the future of WeightWatchers and the effect it could have on its strategy and market valuation.
Oprah Winfrey and WeightWatchers
Oprah Winfrey partnered with WeightWatchers in 2015, purchasing a 10% stake in the company and joining its board of directors..
Their investment and partnership not only boosted WeightWatchers’ image but also increased its market value significantly.
During her time at the company, Winfrey was a powerful voice for positive change, promoting health and wellness beyond simple weight loss.
Over the years, Winfrey not only contributed to the company through her initial investment, but also faced challenges, including fluctuations in the value of the company’s stock. Despite the ups and downs, his commitment to the brand and its message of personal health and wellness remained constant.
The “scandal” of obesity medications
The decision comes a few months after the businesswoman shared with the magazine People that he was using a medication like Wegovy or Mounjaro. Without specifying which brand she was using (although it is speculated to be Ozempic), Winfrey noted that this medicine helps her maintain her weight.
“I took the medication before Thanksgiving because I knew I was going to be eating for two straight weeks and instead of gaining eight pounds like I did last year, I gained half a pound. Calms ‘the noise’ of food,” he told the publication.
He WeightWatchers weight management method is based on a points system that transforms the nutritional information of foods into a unique numbercalled points or propoints.
Oprah Winfrey faced backlash after confirming her use of the weight-loss drug while she is a Weight Watchers ambassador. The businesswoman had previously said that medications used to promote weight loss, such as Ozempic, were “the easy way out.”
Strategy change
Winfrey’s decision to step down from the board coincides with a period of transformation for WeightWatchers, which has been adapting its approach toward a more holistic view of wellness, including the acceptance of weight loss medications as part of its program.
Winfrey’s departure could mean a significant change for WeightWatchers, given her influence in promoting the brand and its ability to attract new customers.
His departure raises questions about how the company will remain relevant and continue to attract a consumer base seeking health and wellness solutions.
It should be noted that after Winfrey’s announcement, WeightWatchers shares plummeted 24 percent.
Editorial Team The editorial team of EMPRENDEDOR.com, which for more than 27 years has worked to promote entrepreneurship.